Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier R, Pittock SJ, Paul F, Kim HJ, Bennett JL, Weinshenker BG, Wingerchuk DM, Green AJ, Fujihara K, Cutter G, Aktas O, Hartung HP, Drappa J, Ratchford JN, She D, Smith M, Rees W, Cimbora D, Katz E, Cree BAC; N-MOmentum study investigators. Marignier R, et al. Among authors: aktas o. Mult Scler Relat Disord. 2022 Jan;57:103356. doi: 10.1016/j.msard.2021.103356. Epub 2021 Nov 1. Mult Scler Relat Disord. 2022. PMID: 35158465 Free article. Clinical Trial.
Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F. Paul F, et al. Among authors: aktas o. PLoS Med. 2007 Apr;4(4):e133. doi: 10.1371/journal.pmed.0040133. PLoS Med. 2007. PMID: 17439296 Free PMC article.
Impact of HMG-CoA reductase inhibition on brain pathology.
Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP. Zipp F, et al. Among authors: aktas o. Trends Pharmacol Sci. 2007 Jul;28(7):342-9. doi: 10.1016/j.tips.2007.05.001. Epub 2007 Jun 15. Trends Pharmacol Sci. 2007. PMID: 17573124 Review.
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
Paul F, Waiczies S, Wuerfel J, Bellmann-Strobl J, Dörr J, Waiczies H, Haertle M, Wernecke KD, Volk HD, Aktas O, Zipp F. Paul F, et al. Among authors: aktas o. PLoS One. 2008 Apr 9;3(4):e1928. doi: 10.1371/journal.pone.0001928. PLoS One. 2008. PMID: 18398457 Free PMC article. Clinical Trial.
Oral therapies for multiple sclerosis: are we there yet?
Hartung HP, Aktas O. Hartung HP, et al. Among authors: aktas o. Lancet Neurol. 2010 May;9(5):454-7. doi: 10.1016/S1474-4422(10)70088-0. Lancet Neurol. 2010. PMID: 20398852 No abstract available.
405 results